Failure of hormone deprivation therapy used to slow prostate cancer in patients leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options. Endostatin, used in combination therapy, may help delay onset of castration-resistant disease.
Marisa Marques, M.D., receives awards for her commitment to apheresis at UAB.
Tina Simpson, M.D., and Marisa B. Marques, M.D., have been recognized by the American Medical Women’s Association for going above and beyond to guide medical students, residents and fellows.
Victor M. Darley-Usmar, Ph.D., endowed professor of Mitochondrial Medicine and Pathology in the UAB School of Medicine, has been named the Associate Dean for Research.
Abnormal antibody production that allows inflammation leading to AIDS is detected by analysis of antibodies in gut fluid of HIV-1-infected people.
The UAB Comprehensive Cancer Center has received a $16 million NCI renewal grant to advance cancer disparities research and reduce mortality rates among underserved populations.
The power and promise of personalized medicine: a genetic test can reduce cardiovascular risk for some heart patients.
This competitive award recognizes outstanding achievements and contributions to VA research and provides five years of salary support.
George Jabboure Netto, M.D., an internationally recognized clinician-scientist, has been named chair of the Department of Pathology.
Researcher X. Long Zheng, M.D., Ph.D., has received a five-year, $2.5 million National Institutes of Health grant to study the pathogenesis of thrombotic microangiopathy, or TMA.